Hannover, 28 February 2019

The highly regarded bloodstock team also includes Underwriters Laura Moore and William Jordan. They are seen as one of the bloodstock leaders in the Lloyd’s and London markets, writing a global book notably in the UK, US, France, Australia and Canada.

Mark Edwards has been in bloodstock for over 30 years. Prior to joining Neon Underwriting (formerly Marketform) in 2008, he was Managing Director of Heath Lambert’s bloodstock division. Cathy Olive has over 20 years’ experience in bloodstock and moved with Edwards to Neon in 2008.

HDI Global Specialty SE launched at the beginning of this year, with the stated strategic aim of combining organic growth with acquisitions of specialty teams and portfolios of high-margin business. Total annual premium volumes are expected to be in excess of €1bn.

Ralph Beutter, CEO of HDI Global Specialty SE, said: “When launching HDI Global Specialty SE in January, I said that we would be creating a strong platform to maximise the opportunities that exist within specialty lines. Bringing in Mark Edwards and his team underlines this strategy and is an early sign of both our intentions, and our commitment to responding to clients’ needs.”

Richard Taylor, member of the Executive Board of Management and UK Managing Director at HDI Global Specialty SE added: “Mark Edwards and his bloodstock underwriting colleagues are one of the most experienced and highly regarded teams in the London market. They are genuine market leaders and an excellent addition to our specialty lines business. We will continue to look for organic and M&A opportunities to grow our profitability in our specialty lines business.”

HDI Global Specialty SE operates from six of its own offices and throughout the HDI Global SE network in 150 countries. It was created from the merging of the specialty lines activities of Hannover Re and HDI Global SE.

About HDI Global Specialty SE

Following approval by the supervisory authorities, HDI Global Specialty rolled-out operational activities on 1 January 2019.

HDI Global Specialty SE is a joint venture of Hannover Re and HDI Global SE, both being strong and established players in the insurance and reinsurance market. Combining the specialty activities of the Talanx Group into HDI Global Specialty SE, is an excellent platform for putting together cross-business segment expertise and network reach writing agency and specialty insurance business in lines including such as errors & omissions liability insurance, directors’ and officers’ liability insurance (D&O), legal expenses insurance, sports and entertainment, aviation, offshore energy and animal insurance.

Specialist local teams are highly qualified to give quick responses and informed support to the client’s local operations, specifically their special, unusual or difficult insurance needs.

For additional information please go to:

About HDI Global SE

As an industrial lines insurer, HDI Global SE (HDI) meets the needs of SMEs, industrial companies and corporate customers with insurance solutions that are specifically tailored to their requirements. In addition to HDI's prominent position in the German and broader European market, the company also has operations in more than 150 countries through foreign branch offices, subsidiary and peer companies, and network partners. The company is thus able to offer its customers local policies for their global operations, which ensure that the established service and insurance protection is extended for all covered risks worldwide.

HDI Global SE is a company in the Talanx Group and manages the Industrial Lines Division within the Group. More than three thousand employees in this division generated gross written premiums of approx. EUR 4.5 billion in the year 2017. The rating agency Standard & Poor’s has given the Talanx Primary Group a financial strength rating of A+/stable (strong). Talanx AG is listed on the Frankfurt Stock Exchange in the SDAX as well as on the stock exchanges in Hannover and Warsaw (ISIN: DE000TLX1005, German Securities Code: TLX100, Polish Securities Code: TNX).

You can find additional information by going to:

About Hannover Re

Hannover Re, with gross premium of EUR 17.8billion, is the fourth-largest reinsurer in the world. It transacts all lines of property & casualty and life & health reinsurance and is present on all continents with around 3,300 staff. Established in 1966, the Hannover Re Group today has a network of more than 140 subsidiaries, branches and representative offices worldwide. The Group's German business is written by the subsidiary E+S Rück. The rating agencies most relevant to the insurance industry have awarded both Hannover Re and E+S Rück outstanding financial strength ratings: Standard & Poor's AA-"Very Strong" and A.M. Best A+ "Superior".

For media enquiries please contact

Emma Heal
Tel.: +44 (0)20 7015 4016
Email: Emma.Heal@hdi-specialty.com

Alex Wise
Full Circle Corporate Communications
Tel: +44 20 7265 7887
Email: awise@fullcirclecomms.co.uk


This news release may include forward-looking statements which are based on certain assumptions, expectations and opinions of the management of Talanx AG and/or HDI Global Specialty SE. These statements are, therefore, subject to certain known or unknown risks and uncertainties. A variety of factors, many of which are beyond Talanx AG’s and/or HDI Global Specialty SE’s control, affect our business activities, business strategy, results, performance and achievements. Should one or more of these factors or risks or uncertainties materialize, actual results, performance or achievements of Talanx AG and/or HDI Global Specialty SE may vary materially from those expressed or implied in the relevant forward-looking statement. Talanx AG and HDI Global Specialty SE do not guarantee that the assumptions underlying such forward-looking statements are free from errors nor do Talanx AG and/or HDI Global Specialty SE accept any responsibility for the actual occurrence of the forecasted developments. Talanx AG and HDI Global Specialty SE neither intend, nor assume any obligation, to update or revise these forward-looking statements in light of developments which differ from those anticipated.